Baranowska Bogusława, Wolinska-Witort Ewa, Wasilewska-Dziubinska Elzbieta, Roguski Krzysztof, Martynska Lidia, Chmielowska Magdalena
Neuroendocrinology Department, Medical Center of Postgraduate Education, Fieldorfa 40, 04-158 Warsaw, Poland.
Neuro Endocrinol Lett. 2003 Dec;24(6):431-4.
It has been reported that neuropeptides may play a role in the control of appetite and in the mechanism of hormone release. Neuropeptides such as beta-endorphin, neuropeptide Y (NPY), galanin and leptin may affect hormones release, on the other hand the hormonal status may modulate neuropeptide activity.
The material consisted of 90 obese women, 30 women with Anorexia Nervosa, and 30 healthy, lean women of control group. Plasma beta-endorphin, NPY, leptin, somatostatin and serum pituitary and gonadal hormones concentrations were measured with RIA methods.
We observed the highest plasma NPY levels in obese hypertensive and diabetic patients. After carbohydrate administration (OGTT) a marked increase of insulin, beta-endorphin and NPY was found. The blunted response of GH to GH-RH may be connected with increased somatostatin activity and hyperinsulinemia. The abnormal response of LH to opioid blockade may be a result of disturbed opioid and NPY activities in obese patients. However in patients with anorexia nervosa, plasma leptin and NPY concentrations were low. The disturbances in beta-endorphin release are also observed.
The neuroendocrine disturbances in obesity and in anorexia nervosa are opposite. The feedback mechanism between leptin and NPY is disturbed in both in obesity and in anorexia nervosa. An abnormal activity of neuropeptides may lead to disturbed control of appetite and hormonal dysregulation in eating disorders.
据报道,神经肽可能在食欲控制和激素释放机制中发挥作用。诸如β-内啡肽、神经肽Y(NPY)、甘丙肽和瘦素等神经肽可能影响激素释放,另一方面,激素状态可能调节神经肽活性。
研究材料包括90名肥胖女性、30名神经性厌食症女性以及30名健康瘦女性作为对照组。采用放射免疫分析法测定血浆β-内啡肽、NPY、瘦素、生长抑素以及血清垂体和性腺激素浓度。
我们观察到肥胖高血压和糖尿病患者血浆NPY水平最高。给予碳水化合物(口服葡萄糖耐量试验)后,胰岛素、β-内啡肽和NPY显著增加。生长激素对生长激素释放激素反应迟钝可能与生长抑素活性增加和高胰岛素血症有关。肥胖患者促黄体生成素对阿片类药物阻断反应异常可能是阿片类药物和NPY活性紊乱的结果。然而,神经性厌食症患者血浆瘦素和NPY浓度较低。也观察到β-内啡肽释放紊乱。
肥胖和神经性厌食症中的神经内分泌紊乱是相反的。肥胖和神经性厌食症中瘦素和NPY之间的反馈机制均受到干扰。神经肽的异常活性可能导致饮食失调中食欲控制紊乱和激素失调。